Defibrotide Intravenous and Hydrocodone Extended-Release Capsules
Determining the interaction of Defibrotide Intravenous and Hydrocodone Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: defibrotide
Brand name: Defitelio
Synonyms: Defibrotide, Defibrotide Sodium
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Defibrotide Intravenous-Hydrocodone Extended-Release Tablets
- Defibrotide Intravenous-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Defibrotide Intravenous-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Defibrotide Intravenous-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Defibrotide Intravenous-Hydrocortisone
- Defibrotide Intravenous-Hydrocortisone (Systemic)
- Hydrocodone Extended-Release Capsules-Defibrotide Sodium
- Hydrocodone Extended-Release Capsules-Definity
- Hydrocodone Extended-Release Capsules-Defitelio
- Hydrocodone Extended-Release Capsules-Deflazacort
- Hydrocodone Extended-Release Capsules-Deflazacort Oral Suspension
- Hydrocodone Extended-Release Capsules-Deflazacort Tablets